Phio Pharmaceuticals Corp. - Common Stock, par value $0.0001 per share (PHIO)

Historical Holders from Q3 2024 to Q3 2025

Symbol
PHIO on Nasdaq
CUSIP
71880W501
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
10.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
188K
Holdings value
$467K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
11
Number of buys
6
Number of sells
-4
Average Value change %
0%
Average buys %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Phio Pharmaceuticals Corp. - Common Stock, par value $0.0001 per share (PHIO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVI Investments, Inc. 9.9% +100% $1.73M $1.52M 733K +706% CVI Investments, Inc. Nov 3, 2025
Orca Capital AG 6.5% +32% $1.48M $617K 700K +71.1% Orca Capital AG Nov 20, 2025
INTRACOASTAL CAPITAL, LLC 7% -29.9% $1.01M -$236K 430K -18.9% Mitchell P. Kopin Sep 30, 2025

Institutional Holders of Phio Pharmaceuticals Corp. - Common Stock, par value $0.0001 per share (PHIO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 188K $467K +$60K $2.48 11
2025 Q2 165K $387K +$165K $2.35 11
2025 Q1 101K $131K -$133K $1.30 10
2024 Q4 154K $277K +$183K $1.80 10
2024 Q3 28.5K $98.3K +$98.3K $3.45 6